| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 4 | |
| #2 | Australia | 3 | |
| #3 | Canada | 3 | |
| #4 | EPO (European Patent Office) | 3 | |
| #5 | Israel | 1 | |
| #6 | Lithuania | 1 | |
| #7 | Norway | 1 | |
| #8 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Heterocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Hirtzer Pamela G | 5 |
| #2 | Braude Irwin A | 5 |
| #3 | Ho Bert | 5 |
| #4 | Khosrovi Behzad | 5 |
| #5 | Petti Samn Raffaniello | 4 |
| #6 | Petti Stephen J | 4 |
| #7 | Shulgin Alexander T | 2 |
| #8 | Jacob Peyton Iii | 2 |
| Publication | Filing date | Title |
|---|---|---|
| AU2005231769A1 | A method of treatment for stroke employing administration of defibrinogenating agents to achieve a specific defibrinogenation pattern | |
| US5780431A | Pharmaceutical formulations of corticotropin releasing factor having improved stability in liquid form | |
| WO9639133A1 | Novel n-substituted-2-amino-3',4'-methylene-dioxypropiophenones | |
| WO9512416A1 | Treatment for rheumatoid arthritis |